Transient interactions between the Anaphase-Promoting Complex/Cyclosome (APC/C) and its activator subunit Cdc20 or Cdh1 generate oscillations in ubiquitination activity necessary to maintain the order of cell cycle events. Activator binds the APC/C with high affinity and exhibits negligible dissociation kinetics in vitro, and it is not clear how the rapid turnover of APC/Cactivator complexes is achieved in vivo. Here, we describe a mechanism that controls APC/Cactivator interactions based on the availability of substrates. We find that APC/C-activator dissociation is stimulated by abundant cellular polyanions such as nucleic acids and polyphosphate. Polyanions also interfere with the ubiquitination of low-affinity substrates.
Nucleic acids and polyphosphate promote dissociation of activators from the APC/C
To further understand what types of RNA molecules provide the dissociation activity, we cloned and sequenced the major RNA species in our active preparation, revealing that the major RNAs in the preparation were tRNAs and rRNA fragments (see Methods). tRNA Gln and tRNA Ser were particularly abundant in the sample. To test their activity directly, tRNA Gln and tRNA Ser were transcribed in vitro and gel purified. Both species removed Cdh1 from the APC/C in the presence of ATP, with similar half-maximal dissociation occurring at concentrations of 0.9 µM and 0.7 µM, respectively (Fig. 3a) .
To determine if the activity was specific for tRNA or could be seen with any RNA species, we transcribed a pool of random RNA sequences of the same length as the glutamine tRNA used above. These RNA molecules removed activator from the APC/C at similar concentrations as tRNA (0.8 µM, Fig. 3b ), suggesting that activator dissociation could be achieved by a variety of RNA sequences. To determine if this mechanism is a general function of nucleic acids, we synthesized two random, complementary 75-base single-stranded DNA oligonucleotides. Both sequences dissociated the activator subunit from the APC/C even more efficiently than RNA, with half-maximal concentrations of 0.2 µM and 0.6 µM (Fig. 3c ). These results suggest that nucleic acids, independent of their sequence, are capable of promoting dissociation of activators from the APC/C.
The above experiments were performed with single-stranded nucleic acid polymers. Compared to double-stranded species, single-stranded nucleic acids exhibit more flexibility and heterogeneity in secondary structure. Slight variations in the dissociation activity of the sequences we tested (particularly differences between two complementary DNA oligonucleotides) suggest that nucleic acid structure and flexibility could play a role in disruption of APC/C-activator interactions. We explored this issue further by annealing the two complementary 75-nucleotide DNA oligonucleotides to reduce their flexibility and structural complexity. This double-stranded DNA dissociated activators less efficiently than either single strand (1 µM, Fig. 3d ). Thus, efficient dissociation might be enhanced by the flexibility or secondary structures of single-stranded nucleic acids.
We also tested the effect of nucleic acid length on activator dissociation. A 75-base singlestranded DNA molecule was more than 5-fold (half maximal concentration 0.15 µM) more potent in activator dissociation than a 50-base oligonucleotide (1.8 µM). A 25-base oligonucleotide had little effect even at high concentrations (Fig. 3e ). The higher activity of longer polymers could result from their greater flexibility and secondary structures. Activator dissociation might also depend on nucleic acid interactions with multiple distant sites on the APC/C and/or activator.
Given that both DNA and RNA can efficiently remove activators from the APC independent of nucleotide sequence, we next investigated if the negatively-charged phosphate backbone of nucleic acids is responsible for activator dissociation. We tested the activity of polyphosphate, long chains of phosphate molecules that are found at high concentrations in cells from every branch of life 30 . In addition to providing energy storage, polyphosphate is believed to alter protein structure and stability through extensive electrostatic interactions with protein surfaces 31 .
We found that a mixed length polyphosphate preparation (45-160 phosphates per chain) was capable of dissociating activators, while similar concentrations of orthophosphate had no effect ( Fig. 3f ). Polyphosphate concentrations required for activator dissociation were higher than those observed with nucleic acids, even if nucleic acid concentration is expressed in terms of total phosphate concentration. We suspect that this reduced potency is due to heterogeneity in polyphosphate chain length. Taken together, our results show that biological polymers containing long chains of negatively-charged phosphates are potent catalysts of APC/Cactivator dissociation.
ATP promotes activator dissociation by sequestering magnesium ions
Our studies suggested that nucleic acids require ATP at millimolar concentrations for efficient activator dissociation ( Fig. 2f, Supplementary Fig. 3a ). Given that ATP alone, even at high concentrations, is not sufficient to dissociate activators ( Supplementary Fig. 3a ), and its hydrolysis is not necessary (Fig. 1e ), it was likely that ATP had other roles in our reactions. To explore this issue further, we tested whether other nucleotides could substitute for ATP. The purified RNA preparation from the flow-through fraction of Fig. 2b displayed dissociation activity when supplemented with 3 mM ATP, AMP-PNP or GTP, and less effectively with ADP, but not with AMP ( Fig. 4a ). We hypothesized that dissociation might simply require molecules containing two adjacent phosphates. Consistent with this possibility, we found that inorganic pyrophosphate and tri-phosphate promoted the ability of DNA to dissociate the activator ( Fig.   4b ).
Phosphates on nucleic acids, polyphosphate chains and free ATP interact with divalent cations such as Mg 2+ . If polymeric negative charges are critical for the ability of nucleic acids and polyphosphate to dissociate activators, then magnesium ions could neutralize this charge and thereby block activator dissociation. Our dissociation reactions contain 2.5 mM Mg 2+ ions, and we therefore hypothesized that millimolar concentrations of ATP promote activator dissociation by sequestering these ions. Consistent with this hypothesis, magnesium ions inhibited DNA-or polyphosphate-dependent activator dissociation in the absence of ATP ( Fig. 4c, d ; Supplementary Fig. 3b ). ATP was not required when single-stranded DNA was used in the absence of magnesium, and the reaction was only slightly enhanced when supplemented with ATP ( Fig 4d) . In reactions containing both ATP and magnesium, we observed that the inhibitory effect of magnesium occurred only when it was in molar excess of ATP ( Fig. 4e , Supplementary   Fig. 3c ). These findings indicate that ATP sequesters magnesium ions to enhance the negative charge of phosphate-containing polymers, which is required for activator dissociation.
Polyanions enhance APC/C substrate selectivity
The APC/C ubiquitinates its targets only when bound by an activator, so dissociation of activators by polyanions should reduce APC/C activity if polyanions are capable of dissociating functional activators. We tested this possibility by measuring APC/C ubiquitination activity toward radiolabeled Pds1/securin in vitro. As predicted, pre-incubation of APC/C Cdh1 with singlestranded DNA prior to the ubiquitination reaction resulted in lower Pds1 ubiquitination ( Fig. 5a ).
To better understand APC/C function in the presence of DNA, we simultaneously measured Pds1 ubiquitination and activator dissociation at various DNA concentrations. Even after just 2.5 minutes of incubation with DNA, Pds1 ubiquitination by APC/C Cdh1 was almost completely inhibited at DNA concentrations of 1 µM or higher (Fig. 5b, c) , despite the fact that a significant amount of Cdh1 remained bound to the APC/C ( Fig. 5b, d ). After 30 minutes, ubiquitination activity remained inhibited and was accompanied by more Cdh1 dissociation ( Fig. 5c, d) . These results revealed that inhibition of APC/C activity by polyanions is not due simply to activator dissociation. Instead, they suggest that inhibition occurs in two steps: immediate inhibition of substrate ubiquitination followed by secondary inactivation due to activator dissociation. We next analyzed the effect of DNA on the ubiquitination of a selection of substrates, using Cdh1 or Cdc20 as activator. We tested three substrates: Pds1 and S-phase cyclin Clb5, both well-established substrates of APC/C Cdc20 in metaphase; and Hsl1, a protein that is ubiquitinated primarily by APC/C Cdh1 in late mitosis but is also an excellent substrate for APC/C Cdc20 in vitro 14,20 . As before, we observed that APC/C Cdh1 activity toward Pds1 was inhibited by singlestranded DNA, with a half-maximal DNA concentration of 0.2 µM ( Fig. 5e ). Interestingly, Pds1 ubiquitination by APC/C Cdc20 was relatively resistant to inhibition ( Fig. 5e ). Results with the Sphase cyclin Clb5 displayed a similar trend, with greater inhibition of activity with APC/C Cdh1 , and resistance to DNA with APC/C Cdc20 (Fig. 5f ). On the other hand, DNA had little effect on ubiquitination of Hsl1 by APC/C with either activator (Fig. 5g) .
The three substrates we tested are likely to have different affinities for different APC/C-activator complexes. Substrate affinity is reflected in the processivity of the ubiquitination reaction: a slower dissociation rate (and thus higher affinity) generally results in a greater number of ubiquitins attached during a single binding event 21,32,33 . Pds1 and Clb5 are both more processively modified by APC/C Cdc20 than APC/C Cdh1 (Lu et al., 2014) ( Fig. 5e , f), suggesting that they have greater affinity for Cdc20 than Cdh1. Hsl1 is an unusual substrate that is modified with extremely high processivity with either activator (Fig. 5g ), and it is known to contain an exceptionally high-affinity D-box that has been used extensively in structural studies of the APC/C 14 . Together, these results suggest that DNA is a less effective inhibitor of reactions with substrates that bind with high affinity, indicating that DNA and substrate compete, directly or indirectly, for binding to the APC/C-activator complex.
D-box binding inhibits polyanion-mediated activator dissociation
Our evidence that high-affinity substrate ubiquitination is resistant to inhibition by DNA led us to test the possibility that high-affinity substrate binding also blocks the effect of DNA on activator dissociation. We purified a fragment of Hsl1 (aa 667-872) that contains the D-box and the KEN box and tested the effect of Hsl1 binding on single-stranded DNA-mediated dissociation. Hsl1 stabilized the bound activator and completely blocked DNA-driven dissociation of Cdh1 from the APC/C (Fig. 6a ).
The D-box of APC/C substrates is known to link the activator subunit to the core APC/C subunit Apc10, and previous work has shown that D-box binding enhances activator binding to the APC/C 20,21 . Similarly, we found that a peptide containing only the Hsl1 D-box was able to block the effects of DNA and polyphosphate on activator dissociation (Fig. 6b, c) . A mutant D-box peptide, or a KEN box peptide, had no effect ( Fig. 6b ).
Polyanionic inhibition of APC Cdh1 activity toward Pds1 or Clb5 (Fig. 5e , f) might result because their D-boxes bind to Cdh1 weakly and cannot compete effectively with polyanions. Consistent with this idea, we found that a peptide containing the Pds1 D-box only partially blocked the ability of DNA to promote Cdh1 dissociation ( Fig. 6d ). In contrast, a Pds1 fragment (1-110aa) that contains the D-box greatly reduced the dissociation of Cdc20 ( Supplementary Fig. 4 ), consistent with the notion that the inhibitory effects of DNA are blocked most effectively by highaffinity D-box binding. Together with our studies of ubiquitination reactions in Fig. 5 , these results argue that a high-affinity D-box interaction holds the activator in a position that blocks the effects of polyanions on substrate ubiquitination and activator dissociation.
DISCUSSION
Precise temporal control of APC/C activity during the cell cycle relies on short-lived interactions between the APC/C and the activator subunit. Our studies suggest that the transient binding of activator to the APC/C is unlikely to result from spontaneous dissociation, which is negligible in vitro. Instead, activator dissociation is accelerated by abundant cellular polyanions such as DNA, RNA and polyphosphate, which also inhibit APC/C activity. The inhibitory effects of polyanions are blocked by strong substrate binding, providing a mechanism to selectively enhance ubiquitination of high-affinity substrates.
There is growing evidence that negatively-charged biopolymers influence the structural dynamics of proteins in the cell. Nucleic acids and polyphosphate exhibit chaperone-like properties, accelerate protein folding, and serve as anti-aggregation agents by solubilizing a variety of protein aggregates in vitro [34] [35] [36] . Long stretches of phosphate residues also inhibit polymerization of multimeric proteins and stabilize soluble structures 37, 38 . Our work reveals that polyanions also influence the dynamics of APC/C-activator interactions, specifically disrupting APC/C-activator binding while leaving the multi-subunit APC/C core intact.
We found that submicromolar concentrations of RNA and DNA promote APC/C-activator dissociation, while polyphosphate acts at submillimolar concentrations. These concentrations are far lower than RNA and polyphosphate concentrations inside the cell. tRNA alone can be found in cells at concentration of approximately 200 µM, while polyphosphate concentration is estimated to be as high as 100 mM 30, 39 . Even if these molecules are partially neutralized by positively-charged ions such as Mg 2+ and other charged macromolecules in the cell, it seems likely that there are sufficient quantities of various negatively-charged polymers to exceed the low concentrations needed in vitro to promote APC/C inhibition and activator dissociation.
The binding of activator to the APC/C is known to be regulated by multiple mechanisms. The best understood is phosphorylation of Cdh1 by cyclin-dependent kinases (Cdks), which is known to reduce Cdh1 binding to APC/C in the cell 10,24,40 . Several Cdh1 phosphorylation sites are found in N-terminal regions that mediate APC/C binding. These regions become less accessible to Cdks upon APC/C binding, suggesting that phosphorylation is likely to block association of free Cdh1 rather than promoting dissociation. Cdc20 binding to the APC/C, on the other hand, is controlled in part by its ubiquitination. Cdc20 levels in late mitosis decrease as a result of APC/C Cdh1 -mediated degradation as well as autoubiquitination. Cdc20 autoubiquitination is also involved in disruption of the mitotic checkpoint complex that blocks APC/C Cdc20 activity during activation of the spindle assembly checkpoint 15,29 . However, there is no indication that activator phosphorylation or ubiquitination is required for the polyanionmediated activator dissociation we observed in cell lysates or with purified components.
In addition to providing new insights into the control of APC/C-activator interactions, we uncovered new clues about APC/C-substrate binding. APC/C substrates contain combinations of one to three degrons, of which the D-box is particularly critical because of its role in linking the activator to the APC/C core. The amino acid sequences of the D-box and other degrons vary in different substrates, and it is likely that these sequences evolved to be accommodated by different APC/C-activator complexes. Substrate affinity for each of the two activators determines the substrate residence time. As a result, these variations are likely to influence processivity of ubiquitination and the timing of substrate degradation in vivo 17 . We found that substrate affinity also controls the ability of polyanions to inhibit APC/C activity: the binding of high-affinity substrates results in resistance to the effects of polyanions, while low-affinity substrates are less resistant. Thus, differences in enzyme processivity with substrates of different affinities are amplified in the presence of polyanions, providing a selectivity filter that promotes ubiquitination of high-affinity targets while suppressing background activity toward low-affinity substrates. Furthermore, the ability of substrate binding to stabilize activator binding could enhance APC/C-activator function at cell-cycle stages when abundant substrates are present.
Our observations with different substrates also suggest that polyanions compete with the substrate D-box for binding to the APC/C-activator complex. This competition provides clues about the mechanism of polyanion action. In the absence of substrate, activators are attached to the APC/C via flexible N-and C-termini, such that the globular WD40 domain does not stably interact with APC/C core and remains mobile. It is plausible that polyanions interact with the APC/C at sites adjacent to the activator that are exposed in the absence of a substrate ( 
MATERIALS AND METHODS

Synchronization and Western Blotting
All yeast strains were derivatives of W303. For western blotting of activators during the cell cycle, yeast cells carrying TAP-tagged Cdc16 (Strain yAM4: Cdc16-TAP::KanMX, MATa) were grown overnight and diluted the next morning. When cells reached OD 0.3, cells were synchronized at 30°C for 3 h with 1 µg/ml a-factor. Following release from the arrest by washing, cells were harvested at various times and lysed by bead beating in lysis buffer as described in the next section. TAP-tagged APC/C was immunoprecipitated with magnetic IgG beads. Cdc20 and Cdh1 were subjected to western blotting with polyclonal goat yC-20 (sc-6731) and yC-16 (sc-8959), respectively.
Activator binding and dissociation
A yeast strain carrying Cdc16-TAP and lacking Cdh1 (Strain DOM1226: cdh1::LEU2, Cdc16-TAP:HIS, MATa) 22,28 was harvested at OD600=1 and flash frozen in liquid nitrogen. Cell pellets were lysed by bead beating in lysis buffer (25 mM HEPES pH 7.6, 150 mM KOAc, 2.5 mM MgCl2, 10% Glycerol, 0.5% Triton X-100, 1 mM PMSF, 1 mM DTT and EDTA-free protease inhibitor mix) and centrifuged at 20,000xg for 15 min at 4°C. The APC/C was immunoprecipitated with IgG-coupled magnetic beads (Invitrogen #14301) at 4°C. Cdc20 and Cdh1 were translated in vitro as described 21,22,28 , using the TnT Quick-Coupled reticulocyte lysate system (Promega #L1170) and 35 S-Methionine (Perkin Elmer #NEG709A001MC). APC/C on beads was incubated with reticulocyte lysate containing Cdc20 or Cdh1 for 30 min at 25°C, followed by washing three times with lysis buffer to remove unbound activator. Dissociation reactions were performed at 25°C by incubating APC/C Cdh1 or APC/C Cdc20 with lysis buffer or with wild-type lysates prepared by bead beating in lysis buffer as above and supplemented with 5 mM ATP. Nucleic acid-dependent dissociation assays were performed with 3 mM ATP unless otherwise noted. To terminate the reactions, APC/C was washed with the same buffer and separated by 10% SDS-PAGE. Gels were dried on Whatman paper, exposed to a Phosphor Screen and scanned in a Typhoon 9400 Imager. Images were analyzed using ImageQuant (GE Healthcare). Fraction of Cdc20 and Cdh1 remaining on the APC/C was calculated relative to the zero timepoint or buffer control. In Fig. 5b , APC/C was immunopurified from lysates of a strain lacking Cdh1 and carrying GFP-tagged Apc1 and TAP tagged Cdc16 (Strain NYH14: cdh1::LEU2, Cdc16-TAP:HIS, Apc1-eGFP:CaURA3, MATa). The Hsl1 fragment used in Fig. 6a was expressed in insect cells and purified using a Strep-tag purification column. Degron peptides used in Fig. 6b-d were purchased from CPC Scientific. Peptide sequences are listed in Supplementary Table 1 .
Partial purification of dissociation activity
Wild-type yeast cells were collected at OD600=1.0, washed twice with PBS, and resuspended in water and flash frozen in liquid nitrogen. Cells were lysed using a coffee grinder in a buffer containing 25 mM HEPES pH 7.6, 25 mM KOAc, 2.5 mM MgCl2, 10% Glycerol, 0.5% Triton-X 100, 1 mM PMSF and protease inhibitor mix. Lysate was cleared by centrifugation at 100,000xg
for 1 h and filtered through a 0.22 µm cellulose filter. Cleared lysate was applied to a Bio-Rad CHT type II ceramic hydroxyapatite column using a peristaltic pump. The column was washed with 15 column volumes of buffer HA-A (25 mM HEPES 7.6, 25 mM KOAc, 10% Glycerol) containing 2.5 mM MgCl2. Samples were eluted with a step phosphate gradient using seven column volumes of the same buffer supplemented with 50 mM, 100 mM, 250 mM, or 500 mM PO4 -. Small portions of the flow-through and elution fractions were concentrated, bufferexchanged into Buffer HA-A with 2.5 mM MgCl2 and tested for activator dissociation in the presence of 3 mM ATP. The activity eluted at 50 mM and 100 mM PO4concentrations. The eluted activity was incubated at 95°C for 15 min and centrifuged at 100,000xg for 1 h at 4°C to pellet precipitated molecules. Cleared boiled samples were dialyzed into Buffer HA-A with 2.5 mM MgCl2 overnight using SnakeSkin Dialysis Tubing (Thermo Fisher #68035) at 4°C. Dialyzed samples were re-applied to the hydroxyapatite column. The vast majority of the dissociation activity did not bind to the column and was collected in the flow-through fraction. This fraction was dialyzed into Buffer HA-A overnight and concentrated 10-fold for further characterization in dissociation assays. The activity in this fraction was stable for more than 2 weeks at 4°C with no significant loss of activity.
RNA preparation and sequencing
RNA species in the flow-through fraction were separated by 10% TBE-urea polyacrylamide gel, and major RNA species (~80 nucleotides) were extracted from the gel and ethanol precipitated.
A 3' DNA adapter (CTATAGTGTCACCTAAATTAATACGACTCACTATAGGG) that contains 5' phosphate and 3' spacers was first 5'-adenylated using a 5'-adenylation kit (NEB #E2610-S) at 65°C for 1 h, then ligated to purified RNA species using T4 RNA Ligase 2 Truncated (NEB #M0242S) at 25°C for 1 h. The ligation reaction was separated on a 10% TBE-urea polyacrylamide gel, and ligated products were gel purified. Next, a 5' RNA adapter (GCAATTAACCCTCACTAAAGGAGTCGT) lacking 5' phosphate was ligated with T4 RNA Ligase 1 (NEB #M0204S). Ligation products were gel-purified, and cDNA was synthesized using RT primer (CCCTATAGTGAGTCGTATTAATTTAGGTGACACTATAG) and Superscript IV reverse transcriptase (Thermo-Fisher #18090010). After RNase H digestion, cDNAs were amplified using T7 (TAATACGACTCACTATAGGG) and T3 (GCAATTAACCCTCACTAAAGG) primers. PCR products were cloned into TOPO vectors and transformed into DH5-a cells. After overnight growth and plasmid isolation, sequencing was performed using M13 Forward and Reverse primers. Alignment of sequencing results with the S. cerevisiae S288C genome revealed the presence of tRNAs (tQ(UUG), tS(AGA), tG(CCC), tD(GUC), tE(CUC), tW(CCA), tR(CUC), tL(UAG)) and similar lengths of rRNA fragments (RDN25-1).
Nucleic acid preparation for dissociation reactions
Sequences used in dissociation assays are listed in Supplementary Table 1 . RNA sequences were transcribed in vitro as previously described 42 using T7 RNA Polymerase (NEB #M0251).
Chemically synthesized DNA oligonucleotides or transcribed RNA species were separated on a TBE-urea polyacrylamide gel, purified, ethanol precipitated and resuspended in Buffer HA-A with or without 2.5 mM MgCl2. Medium chain polyphosphate was obtained from Kerafast (p100 #EUI005) and resuspended in Buffer HA-A without MgCl2.
APC/C ubiquitination assay
Yeast cells carrying Cdc16-TAP and lacking Cdh1 were collected at OD600=1, flash frozen, and lysed using beat beating in lysis buffer. APC/C was immunopurified on IgG beads and activated by in vitro translated Cdc20 or Cdh1. Cdc20 and Cdh1 used in Fig. 5e -g were expressed in insect cells using the baculovirus system and purified using Strep-tag purification methods. For APC/C substrates, Pds1, Hsl1 fragment (aa 667-872), and Clb5 were C-terminally ZZ-tagged, cloned into plasmids under control of the T7 promoter, and translated in vitro using 35 S-Methionine. Substrates were purified using IgG-coupled magnetic beads and cleaved with TEV protease (Thermo Fisher #12575015). E1 and E2 (Ubc4) were expressed in E. coli and purified as previously described 43, 44 . E2 charging was performed in a reaction containing 0.2 mg/ml Uba1, 2 mg/ml Ubc4, 2 mg/ml Methylated ubiquitin (Boston Biochem #U-501) and 1 mM ATP at (Fig. 2b) .
Reactions were supplemented with 2.5 mM MgCl2 and 3 mM of the indicated nucleotides. 
